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DNA damage and transcriptional 
regulation in ipsC-derived neurons 
from Ataxia telangiectasia patients
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Ataxia telangiectasia (A-t) is neurodegenerative syndrome caused by inherited mutations inactivating 
the ATM kinase, a master regulator of the DNA damage response (DDR). What makes neurons 
vulnerable to ATM loss remains unclear. In this study we assessed on human iPSC-derived neurons 
whether the abnormal accumulation of DNA-Topoisomerase 1 adducts (Top1ccs) found in A-T impairs 
transcription elongation, thus favoring neurodegeneration. Furthermore, whether neuronal activity-
induced immediate early genes (IEGs), a process involving the formation of DNA breaks, is affected by 
ATM deficiency. We found that Top1cc trapping by CPT induces an ATM-dependent DDR as well as an 
ATM-independent induction of IEGs and repression especially of long genes. As revealed by nascent 
RNA sequencing, transcriptional elongation and recovery were found to proceed with the same 
rate, irrespective of gene length and ATM status. Neuronal activity induced by glutamate receptors 
stimulation, or membrane depolarization with KCl, triggered a DDR and expression of IEGs, the latter 
independent of ATM. In unperturbed A-T neurons a set of genes (FN1, DCN, RASGRF1, FZD1, EOMES, 
SHH, NR2E1) implicated in the development, maintenance and physiology of central nervous system 
was specifically downregulated, underscoring their potential involvement in the neurodegenerative 
process in A-T patients.
Ataxia Telangiectasia (A-T) is an inherited syndrome manifesting early onset neurodegeneration, cancer predis-
position, immunodeficiency, telangiectasias, and at cellular level radiosensitivity, chromosomal instability and 
cell cycle checkpoint defects1. Neuropathological abnormalities in A-T include progressive death of cerebellar 
Purkinje and granular, cells, moderate decay of the bulbar olivae in the brainstem, and mild loss of myelinated fib-
ers in corticospinal and spinocerebellar tracts2. A-T is caused by loss of function mutations in ATM gene, which 
encodes a protein kinase acting in the nucleus as the apical sensor and transducer of DNA double strand breaks 
(DSBs). ATM is rapidly activated by DSBs and recruited at sites of lesions, inducing the phosphorylation at TQ/
SQ residues of several downstream proteins implicated in cell cycle checkpoints arrest, repair of DSBs, local chro-
matin remodelling, apoptosis and senescence3. Besides its primary role in DNA damage response (DDR), ATM 
has been implicated in redox-sensing and proteostasis4, mitochondrial homeostasis via mitophagy5, autophagy of 
peroxisomes6. Very recently, cytoplasmic ATM was shown to segregate with and regulate endocytosis of synaptic 
vesicles, as opposite to ATR which associates with inhibitory vesicles7.
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Currently, it is uncertain what renders neurons hypersensitive to ATM deficiency. In line with the canonical 
function of ATM in DDR, brain degeneration in A-T has been ascribed to the inappropriate DNA repair in pre- 
and post-mitotic neurons, boosting the rate of genotoxic lesions. However, increased oxidative stress and reduced 
anti-oxidant defense, themselves reflecting a non-canonical cytoplasmic activity of ATM, may equally play a role 
in A-T, considering that high oxygen consumption and metabolic activity expose brain neurons to elevated ROS 
levels that can induce abundant SSBs8,9. Neurodegeneration has also been ascribed to transcriptional decline of 
genes implicated in synaptic vesicle trafficking and release10,11. Interestingly, an age-dependent accumulation of 
mutations believed to arise during transcription has been detected at single-neuron level in normal individuals 
and to a greater extent in DNA repair-deficient neurodegenerative syndromes12,13. A connection between ATM 
and Topoisomerase 1 (Top1) in the maintenance of transcription integrity has recently emerged. Top1 relaxes 
DNA supercoiling generated by transcription, replication and chromatin remodeling via transient formation 
of Top1-DNA covalent complexes (Top1-cc) and introduction of SSBs. The proteolytic removal of Top1-ccs, an 
essential step to avoid collision with the replication or transcriptional machinery and conversion of SSBs into 
lethal DSBs14, is ATM-dependent15, and the accumulation in ATM deficient cells of Top1-ccs15,16 and aberrant 
DNA lesions17 underscores their neuropathogenic relevance in A-T. A recent hypothesis suggests that A-T brain 
degeneration might arise from dysfunctional glial cells, in turn impairing the functionality and viability of neural 
cells18.
Patient-derived induced pluripotent stem cells (iPSCs) differentiating into mature neurons offer a powerful 
in vitro system to model neurological diseases19,20. Using this approach, we investigated the response of A-T and 
normal (WT) neurons to various stimuli and impact on transcription, to identify factors and mechanisms of 
neuropathological relevance for A-T.
Results
hiPSC-derived normal and A-T neurons. The hiPSCs used in this study were established from der-
mal fibroblasts of two unrelated A-T patients (A-T1 and A-T2) and two healthy controls (WT1 and WT2), as 
described16,21 and further detailed in the Methods and Supplemental data sections. The phenotypic and electro-
physiological properties of the hiPSC-derived neurons from WT2 and A-T2 have been reported16, while those 
from WT1 and A-T1 are found in Suppl. Figs 1–4.
CPT activates an ATM-dependent DDR. We previously reported that human postmitotic A-T neurons 
exhibit an abnormal accumulation of topoisomerase 1 covalently bound to DNA (Top1-cc)16, in agreement with 
findings in mouse Atm−/− neural and MEF cells15,17,22. Top1 activity facilitates transcription by introducing tran-
sient breaks on one strand of the DNA especially in gene bodies, which dissipate supercoiling and stimulate RNA 
Pol II pause release23,24. It has also been shown that ATM loss markedly delays transcription recovery following 
release from Top1-cc trapping15.
To determine whether the elevated levels of Top1-cc affected transcription, we first analysed the 
ATM-dependent DDR in postmitotic neurons treated with CPT for 1 hr, and then allowed to recover for 3hrs 
after drug washout. This treatment schedule, which was not cytotoxic, according to viability tests and absence of 
cleaved PARP (not shown), induced in WT neurons the autophosphorylation of ATM on Ser1981 (an indicator 
of its kinase activity) and phosphorylation of its substrates KAP1-Ser824, Chk2-Thr68 and p53-Ser15, both at 1 hr 
and 3hrs post-recovery (Fig. 1), whereas in A-T neurons these modifications were markedly attenuated. The DNA 
damaging effect of CPT in WT neurons resulted in the formation at 1 hr of 53BP1 nuclear foci (Suppl. Fig. 5a), 
most being resolved during the next 3 hrs, while in A-T these foci were less evident, concordant with the fact that 
ATM deficiency attenuates the DDR. The DSB-inducing agent neocarzinostatin (NCS) used as positive control, 
gave similar results (Suppl. Fig. 5a).
CPT-induced transcriptional changes, and correlation with gene length. As Top1 inhibitors in 
mouse neurons repress the global gene expression25,26, we performed exon microarray analysis to determine the 
transcriptional impact of Top1-cc blocking on WT2 neurons pretreated or not with the ATM inhibitor Kudos-
55933 (WT2-ATMi). The ablation of the CPT-induced phosphorylation of ATM substrates validated the effec-
tiveness of the inhibitor (Suppl. Fig. 5b). CPT treatment caused in WT2 neurons the upregulation of 370 genes 
and downregulation of 109, while in WT2-ATMi the upregulation of 355 genes and downregulation of 128 
(Fig. 2a and Suppl. Table 1 for the full list of modulated genes). GSEA analysis of WT2 neurons showed, for the 
upregulated genes, enrichment for “cellular response to stress and hormones” and “RNA metabolism” pathways, 
and for the downregulated genes enrichment for pathways involved in”neural development and differentiation”, 
“metabotropic signal transduction”, “nucleotides and metabolism“ (Fig. 2b and full list in Suppl. Table 2).
Since Top1 inhibition in mouse neurons suppresses the expression of long genes by impairing transcription 
elongation23,25,26, we determined the correlation among the CPT-modulated genes with gene length. We found 
that the length of the downregulated genes was on average significantly greater (175 Kb) than those upregulated 
(125 Kb) in both WT2 and WT2-ATMi groups (Fig. 2c).
CPT induces the expression of immediate early genes (IEGs) irrespective of ATM. The exon array 
analysis also revealed that CPT upregulated in WT2 and WT2-ATMi neurons a number of IEGs such as NPAS4, 
FOS, FOSB, EGR1 and ARC (Fig. 3a), many of which encode transcription factors27. In the CNS, IEGs are rap-
idly induced by synaptic activity, promoting in turn the expression of late-response genes, eg: Bdnf and Nptx2, 
that are crucial for synaptic plasticity, learning and memory27,28. The exon microarray findings were validated 
by qRT-PCR assays on separate cultures of WT1 and A-T1 neurons, and in all cases CPT upregulated the IEGs 
(Fig. 3b), confirming the ATM-independence of this response. Furthermore, the accumulation of ARC and c-Fos 
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proteins in WT1, WT1-ATMi and A-T1 neurons became evident at 3hrs post-recovery from CPT treatment and 
persisted up to 7hrs (Fig. 4a,b).
Transcription elongation in WT and ATM-deficient neurons. Topoisomerases are indispensable in 
transcription and their deregulation is associated with neurodegenerative diseases14. Specifically, Top1 dele-
tion represses both in mouse and human neurons the expression of extremely long genes23,25. The evidence that 
ATM-deficient cells overexpress Top1-ccs15,16 raised the question whether this abnormality might affect transcrip-
tion elongation in neurons. To verify this possibility, we performed RNAseq analysis on nascent RNA, purified 
as detailed in Methods, from WT2 and A-T2 neurons that were: i) untreated (Untr); ii) treated with CPT for 
1 hr (R0); iii) treated with CPT for 1 hr and cultured in drug-free medium for 15 min (R15) or 30 min (R30). 
Transcripts differentially expressed between R0 and Untr conditions accounted for 3813 in WT2 and 3397 in 
A-T2, for a total of 7210 transcripts of which 1544 were common to both groups while the remaining 5666 were 
not. To depict changes in transcription rescue between WT2 and A-T2 neurons, hierarchical clustering analysis 
was done on the 5666 differentially expressed transcripts (Fig. 5a and Suppl. Table 3). Hierarchical clustering 
highlighted different expression patterns: i) genes with a similar profile in WT2 and A-T2, independent of the 
treatment conditions (Fig. 5a, red cluster); ii) genes showing an increased expression in A-T2 compared to WT2 
(Fig. 5a, green cluster); iii) genes with an increased expression only in A-T2 upon removal of CPT (Fig. 5a, yel-
low cluster); iv) genes with a reduced expression in A-T2, irrespective of the treatment conditions (Fig. 5a, grey 
cluster). However, none of the expressed genes in A-T2 selectively showed a reduced efficiency in transcription 
rescue compared to WT2.
The potential differences between A-T2 and WT2 at the level of efficiency of transcription recovery in long 
transcripts were further investigated using transcripts coverage, which provides for a given transcript a profile 
of the exons expression and position. Coverage analysis was used to estimate if asymmetries in transcription 
rescue efficiency could be detected between A-T2 and WT2 upon CPT washout. In brief, ENSEMBL transcripts 
(197898) were divided into three length groups (Fig. 5b): (i) ≤175 nts (7872 transcripts), (ii) >175 nts ≥1300 
nts (122719 transcripts) ad iii) >1300 nts (67307 transcripts). Coverage comparison analysis was done only for 
transcripts longer than 1300 nts. Coverage was calculated for these transcripts in each experimental specimen, 
and then Pearson correlation between R0 and Untr was determined in A-T2 and WT2 samples. Only transcripts 
showing coverage profile changes induced by CPT were retained for the subsequent analysis, i.e. Pearson corre-
lation <0.2. Coverage profile changes were observed in 27 A-T2 and 33 WT2 transcripts, of which 11 transcripts 
were in common (Fig. 5c). Thus, the total number of transcripts, in which coverage is affected by CPT treatment 
in A-T2 or WT2 are 49. Dissimilarities in coverage profiles between A-T2 and WT2 were investigated on these 
49 transcripts comparing the coverage in Untr with respect to R15 or R30 specimens. Coverage dissimilarity was 
estimated using the integrative correlation analysis (ICC)29. ICC was developed for quantification of the extent 
to which independent studies can be reliably analyzed together for the systematic comparison of transcription 
profiles30. This analysis did not detect any consistent change between A-T2 and WT2 groups (not shown).
Figure 1. CPT induces the ATM activation and DDR nuclear foci. DIV30 neurons were treated for 1 hr with 
CPT and collected either immediately or 3 hrs after drug washout. The DDR was evaluated by Western blot 
using phospho- and pan-specific antibodies. β-Actin and vinculin are protein loading controls.
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Figure 2. CPT treatment affects global gene expression in neurons. DIV30 WT2 neurons were untreated or 
treated for 1 hr with CPT and harvested 3hrs after drug washout; the ATM inhibitor was added 1 hrs prior to 
CPT. Gene expression and alternative splicing of the samples was analysed using the gene chip human exon 
array. (a) Volcano plots depicting the log2 fold change (FC, X-axis) of the significantly up- and down-regulated 
genes in relation to log10 false discovery rate (FDR, Y axis). The number of CPT-modulated genes is indicated 
in the left (FC ≤ −2 and FDR < 0.05) and right (FC ≥ 2 and FDR < 0.05) quadrants of the plots. (b) Interaction 
nodes and clusters for the differentially expressed positively and negatively enriched gene sets (FDR < 0.005), 
generated from WT2 (untreated vs CPT treated) using Cytoscape. On the right are reported the top five DEGs 
for each cluster’s assigned biological function. (c) Scatter plot of the correlation (R) between the log10 gene 
length (X axis) and the t-statistic (Y axis) for the up- and down-regulated genes.
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Neuronal activity induces an ATM-dependent DNA damage response. Synaptic activity in murine 
neurons elicits a rapid phosphorylation of proteins at S/TQ, a typical consensus site for ATM and other PIKK 
family kinases31. To find out whether human neurons exhibit a similar response, electrophysiologically active 
DIV55 neurons (see above and ref 16) were treated with AMPA and NMDA to stimulate ionotropic glutamate 
receptors, or depolarized with KCl, and assessed for ATM activity. Immunoblot analysis of NMDA-stimulated 
WT2 neurons showed highest levels of ATM-Ser1981 autophosphorylation and phosphorylation of its substrates 
KAP1-Ser824 and Chk2-Thr68 between 20 and 30 min (Fig. 6a, lanes 3–4), a response abolished by pre-treatment 
with the NMDA receptor antagonist MK801 (Fig. 6a, compare lanes 3 and 5), demonstrating the NMDA recep-
tor specificity. Conversely, no ATM signalling was detected in NMDA-treated A-T2 and WT2-ATMi neurons 
(Fig. 6b), highlighting the ATM-dependence of this phenomenon. AMPA, like NMDA, induced in WT2 neurons 
an ATM response within 20 min (Suppl. Fig. 6). Similarly, KCl-induced membrane depolarization, elicited an 
Figure 3. IEGs are transcriptionally induced by CPT treatment. DIV30 neurons were treated and subjected 
to exon array analysis as in Fig. 2. (a) Heat map depicting the expression of IEGs induced by CPT, in relation 
to ATM activity. (b) qRT-PCR analysis of ARC, EGR1, FOS and GAPDH (the latter used for normalization) 
performed on mRNA extracted from WT1 and A-T1 neuronal preparations. Data are average of six 
experiments +/−SD and results normalized against those of GAPDH (* p < 0.05; **p < 0.01).
www.nature.com/scientificreports/
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ATM signalling in WT1, but not A-T1 or ATM-KO1 neurons (Fig. 6c), the latter derived from WT1, in which the 
ATM gene was knockout by CRISPR (Suppl. Fig. 7 for characterization of the clone).
Various paradigms of neuronal stimulation in vivo or in culture have shown to induce DSBs32,33 found to map 
within promoters of IEGs and to be indispensable for their transcription33,34. DNA breaks and DDR play also a 
positive role in transcriptional elongation of stimulus-inducible genes35. To determine whether DNA breaks also 
occur in activity-stimulated human neurons, we analysed the phosphorylation of H2AX-Ser139 (γ-H2AX), a 
target of ATM and known biomarker of DSBs, and found increased levels of γ-H2AX by already 10 min of depo-
larization with KCl in WT1, but not ATM-KO1 or A-T1 neurons (Fig. 6c), and a similar response was evoked 
by NMDA or AMPA stimulation (not shown). Altogether, these findings indicate that human neuronal activity 
initiates an ATM signalling cascade, most likely emanating from DNA damage.
Neuronal activity induces the expression of IEGs independent of ATM. To determine whether 
physiological stimuli induce a similar expression of the IEGs as CPT, we analysed the levels of c-Fos and ARC 
after treatment of with KCl, and found an accumulation of these proteins by 2hrs of depolarization, both in 
WT1, A-T1 and ATM-KO1 neurons (Fig. 7). The induction of IEGs in WT1 neurons was not prevented by 
pre-treatment with ATMi.
To identify transcriptomic differences in relation to neuronal activity and ATM expression, we performed 
RNA-Seq analysis on WT1, A-T1 and ATM-KO1 neurons treated or untreated with KCl for 1 hr. A group of 
differentially expressed up- and down-regulated genes (DEGs) was identified for each neuronal line following 
KCl-depolarization (Suppl. Table 4). The representation of these DEGs as Venn diagram (Suppl. Fig. 8) allowed us 
to define genes shared between WT1, A-T1 and ATM-KO1 neurons. Specifically, a small set of genes that included 
NR4A3, FOS, NR4A1 and NPAS4 (Fig. 8a), was strongly upregulated after treatment in all three cell lines. These 
genes belong to the IEGs family27,36,37, typically induced by depolarizing stimuli in vitro and sensory stimuli in 
vivo28. Concordant with the immunoblots (Fig. 7a), the RNA-Seq data confirm that the physiological induction 
of IEGs, such as FOS, is mainly ATM independent. RNA-Seq data were validated by RT-PCR analysis of the FOS 
transcript in treated and untreated samples (Suppl. Fig. 9). Of note, PPP1R15A, a gene implicated in DDR and 
cellular stress38, was transcriptionally induced only in stimulated WT1 neurons (Suppl. Table 4). This specific 
Figure 4. CPT induces the protein expression of IEGs. Western blots were performed on DIV30 neurons 
treated for 1 hr with CPT and collected immediately and 3hrs (a) or at later time (b) after drug washout. The 
ATM inhibitor was added 1hr prior CPT and left throughout the experiment. Vinculin and β-Actin are loading 
controls for proteins.
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induction might be explained by the activation of the DDR elicited by the accumulation of activity-dependent 
DSBs, which is known to be defective in A-T cells.
A-T and ATM-KO neurons share significant differences in the basal transcriptomic profile com-
pared to WT neurons. To find out if ATM deficiency affects the basal transcriptional signature, we com-
pared the RNA-Seq profiles of the unperturbed WT1, A-T1 and ATM-KO1 neurons. Genes found differentially 
expressed in A-T1 and ATM-KO1 relative to WT1 are listed in Suppl. Table 5. Specifically, in A-T1 neurons the 
number of up- and down-regulated genes accounted for 392 and 345, respectively, whereas in ATM-KO1 neurons 
261 genes were down-regulated and only 24 up-regulated. A-T1 and ATM-KO1 neurons shared 2 genes that were 
upregulated and 26 down-regulated (Suppl. Fig. 10a,b). A Gene Ontology (GO) analysis performed on the down-
regulated gene set revealed an enrichment in biological processes related to neural development, maintenance 
and physiology of the CNS, a finding of potential relevance for the neuropathological abnormalities affecting the 
cerebellum, cerebrum, spinal cord and brain stem of A-T patients2. The heatmap of the genes annotated to the 
selected GO term (FN1, DCN, RASGRF1, FZD1, EOMES, SHH, NR2E1) is shown in Fig. 8b. The function of 
these genes is detailed in the Discussion section below and the legend to Suppl. Fig. 10.
Discussion
A-T is an inherited multisystemic disorder with early onset brain degeneration, caused by mutations inactivating 
the ATM kinase best known for its apical role in DDR signalling. In accordance with this, neurodegeneration in 
A-T has been attributed to a dysfunctional DNA repair and genome instability accumulating during neurodevel-
opment, ultimately compromising the mature neurons. However, separate from its canonical role in DDR, ATM 
has been found involved in intracellular ROS sensing, protection from oxidative DNA damage and regulation of 
oxidative metabolism4, in ROS-dependent peroxisomal homeostasis via pexophagy6, and mitochondrial home-
ostasis through its capacity to regulate mitophagy5. The protection afforded by ATM against oxidative stress may 
be crucial for viability of neurons, which have an extremely high metabolic rate coupled with excessive ROS 
Figure 5. Hierarchical clustering analysis of differential expression at transcripts and exons level. (a) Log2 
expression ratio between CPT treated and untreated cells for the 5666 transcripts detected as differentially 
expressed in at least one of the two experimental groups, i.e. WT2 and A-T2. (b) ENSEMBL transcripts 
distribution as function of transcripts’ length. Dashed lines indicate the three groups of transcripts, from left 
to right, ≤175 nts (7872 transcripts), (ii) >175 nts ≥1300 nts (122719 transcripts) ad (iii) >1300 nts (67307 
transcripts). (c) Transcripts showing a Pearson correlation below 0.2, in all replicates, comparing CPT treated vs 
untreated WT2 and A-T2 neurons.
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Figure 6. Physiological stimulation of neuronal activity induces a DDR signalling. DIV55 neurons were treated 
with NMDA or KCl for up to 30 min and analysed for the phosphorylation of ATM targets. To inhibit action 
potential, neurons were pre-incubated overnight with the sodium channel blocker TTX. (a) Time-dependent 
phosphorylation of ATM targets induced by NMDA. Pre-incubation for 1 hr with the NMDA receptor 
antagonist MK801 was also performed (lane 5). (b) The ATMi was added 1 hr prior to treatment for 20 min with 
NMDA or KCl. (c) Time-dependent phosphorylation of ATM targets upon KCl-depolarization. Vinculin and 
β-Actin are loading controls for proteins.
Figure 7. Neuronal activity enhances the expression of ARC and c-Fos proteins DIV55 neurons were incubated 
overnight with TTX, thereafter with KCl for up to 4hrs and assessed by Western blot for c-Fos and ARC 
proteins. Note the ATM-independent induction of these IEGs, as also evident from the WT1 treated with ATMi 
(right panel). Vinculin and β-Actin are loading controls for proteins.
www.nature.com/scientificreports/
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by-products. The loss of an effective antioxidant defence, as in ATM deficiency, may thus represent a contributing 
factor to neurodegeneration in A-T.
Neurodegeneration has also been linked to transcriptional decline and downregulation of synaptic genes 
in the CNS10,11. Moreover, the transcription of especially long genes depends on active Top1ccs, which intro-
duce SSBs that reduce DNA torsion generated by elongating RNA pol II. The transiently formed Top1ccs are 
then removed to avoid conversion of SSBs into lethal DSBs14, and this process requires ATM, and indeed ATM 
deficient cells show an accumulation of Top1ccs as well as of aberrant DNA lesions and delayed transcriptional 
recovery15–17.
Here, we have shown that Top1 inhibition by CPT elicits in WT neurons an ATM-dependent signalling 
response that is absent in A-T neurons. Moreover, CPT induced transcriptional changes, including the upregula-
tion of genes enriched for “cellular response to stress and hormones” and “RNA metabolism” and downregulation 
of genes enriched for “neural development and differentiation” “metabotropic signal transduction”, “nucleotides 
and metabolism”. In agreement with data showing that Top1 blocking impairs transcriptional elongation espe-
cially of long genes23,25,26, we found that the length of the CPT-downregulated transcripts was on average greater 
than those being upregulated in WT neurons. Notably, ATM inhibition, despite repressing the DDR, did not 
affect the length of the CPT-modulated genes, excluding ATM as having a role in Top1cc-dependent transcrip-
tional elongation.
To investigate this issue more thoroughly, we performed RNA-seq analysis on nascent RNA from WT and A-T 
neurons exposed to CPT for 1 hr and then released in drug-free medium for 15 and 30 min to recover transcrip-
tion. The bioinformatics analysis of the RNA-seq data performed both at transcript and exon level, however, did 
not show any differential transcriptional rescue behavior between WT and A-T neurons. Moreover, more detailed 
coverage analysis performed on transcripts subdivided into three length groups showed again no major differ-
ences in the efficiency of transcription recovery, altogether excluding a role for ATM in transcription elongation 
in postmitotic neurons.
Among the CPT-upregulated genes were those categorized as IEGs, which in the CNS are rapidly induced 
by synaptic activity and crucial for synaptic plasticity, learning and memory28. Of note, the induction of IEGs by 
CPT, seen at mRNA and protein level (for FOS and ARC), was independent of ATM protein expression or kinase 
activity.
Synaptic activity in mouse neurons induces the phosphorylation of proteins at S/TQ putative consensus sites 
for ATM/ATR kinases31. We have expanded these findings by demonstrating that human neuronal activity elicited 
by ionotropic glutamate receptors stimulation, or depolarization by KCl, causes the phosphorylation of different 
proteins at S/TQ sites, a phenomenon dependent on ATM as it is repressed in A-T and ATM-KO neurons. The lack 
of these phosphorylations in ATM-deficient neurons prompted us to determine the effects on IEGs, but regard-
less of the presence or activity of ATM, neuronal stimulation invariably induced the expression of IEGs, both at 
mRNA and protein level. These findings, coupled with the evidence that physiological stimuli in mouse neurons 
induce DSBs on IEGs promoters, necessary for their transcription32,33, suggest that the increased expression of 
γH2AX (a phosphorylation target of ATM and surrogate marker for DSBs) in our neurons is the consequence of 
activity-induced DSBs, as in mouse neurons. However, it remains to be established by a direct approach to which 
loci within the genome the potential DSBs map in our stimulus-responsive WT and ATM-deficient neurons.
Figure 8. Neuronal activity-induced IEG and basal transcriptional expression. WT1, A-T1 and ATM-KO 
neurons at DIV55 were incubated overnight with TTX and then untreated or treated with KCl for 1 hr, 
harvested and analysed by RNA-seq. (a) Heat map of the stimulus-induced IEGs. (b) heat map of genes 
differentially expressed in unperturbed WT1 compared to A-T1 and ATM-KO1 neurons. These genes are 
involved in CNS development, maintenance, and synaptic plasticity. Data are of two independent replicates.
www.nature.com/scientificreports/
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To identify possible differences in activity-dependent gene expression in relation to ATM status, we performed 
RNA-Seq analysis in WT1, A-T1 and ATM-KO1 neurons depolarized with KCl, and for each cell type we identi-
fied a set of differentially expressed genes (up- and down-regulated) associated with neuronal activity. Despite the 
small number of DEGs identified, likely due to the short treatment time (1 hr), nevertheless the IEGs (eg: NR4A3, 
FOS, NR4A1 and NPAS4) were among those being upregulated regardless of ATM activity, again confirming the 
previous qRT-PCR and Western blot data.
We also sought to determine the impact of ATM deficiency on the transcriptional signature of unperturbed 
neurons and identified a set of genes (FN1, DCN, RASGRF1, FZD1, EOMES, SHH, NR2E1) that were downregu-
lated in both A-T1 and ATM-KO1 compared to WT1. Of these, RASGRF1 is a Ca2+ activated protein involved in 
spinogenesis of primary hippocampal cultures. The nuclear receptor NR2E1 (also known as TLX) participates in 
synaptic plasticity and dendritic structure formation in the dentate gyrus39, in neurogenesis, learning and mem-
ory40. EOMES transcription factor regulates neurogenesis in the subventricular zone (SVZ)41. The morphogenic 
factor SHH is involved in the cerebellar development and proliferation of granular cell precursors, differentiation 
of Bergmann glial cells and normal Purkinje neuron development42,43.
In conclusion, we have shown that hiPSC-derived A-T neurons have an impaired DDR to CPT, like what seen 
with other genotoxic agents16. Additionally, CPT induces an ATM-independent expression of IEGs implicated 
in neuronal activity. We also established through nascent RNA-Seq analysis, that ATM deficiency does not affect 
transcription elongation, not even of long genes.
Most importantly, neuronal activity elicited by NMDA or AMPA receptor agonists, or depolarization with 
KCl, triggered an ATM-dependent DDR and an ATM-independent expression of IEGs. The ATM-dependent 
signalling might presumably reflects a response to the actual DSBs generated within promoters of IEGs33. In stim-
ulated A-T neurons, albeit this signalling is repressed owing to ATM deficiency, the generation of DNA breaks is 
assumed to occur normally, as the induction of IEGs is not prevented. The role, if any, of ATM in the proper repair 
of these transient breaks is unknown. Finally, the transcriptomic analysis has revealed a set of genes whose basal 
downregulation in ATM-deficient neurons relative to WT neurons might be relevant for the neurodegenerative 
phenotype of A-T.
Methods
An expanded version of the experimental procedures appears in the Supplementary data section that accompa-
nies this manuscript.
Fibroblast reprogramming and hiPSCs derivation. Human dermal fibroblasts were from a male 
healthy donor (WT1) (Coriell Institute Biobank, Camden, New Jersey, USA) and from an Ataxia Telangiectasia 
patient (A-T1). The A-T patient’s parents gave informed consent for skin biopsies and the Ethics Committee at 
the Children’s Memorial Health Institute (IPCZD) approved the study. Further, all methods were performed in 
accordance with the experimental protocols approved by the Ethics Committee at the Children’s Memorial Health 
Institute (IPCZD). Fibroblasts were cultured in DMEM F-12 supplemented with 15% Fetal Bovine Serum (both 
from Thermo Fisher Scientific), 2 mM L-glutamine, 0.1 mM non-essential aminoacids,100 units/mL penicillin, 
100 µg/mL streptomycin (all from Lonza) and split with Trypsin/EDTA solution (LONZA). Integration-free hiP-
SCs clones were generated44 by transfecting 7 × 105 fibroblasts with 3 μg of the episomal plasmids pCXLE-hUL 
(expressing L-MYC and LIN28; Addgene #27080), pCXLE-hOCT3/4-shp53-F (expressing OCT3/4 and shRNA 
against p53; Addgene #27077), pCXLE-hSK(expressing SOX2 and KLF4; Addgene #27078), and pAD-KLF4 
(Addgene #19770) for the expression of the large isoform of Klf4 known to increase reprogramming efficiency45. 
Transfections were carried out using the Nucleofector solution Kit for Human Dermal Fibroblast and the 
Nucleofector I Device (U-20 program, Amaxa Biosystems, Lonza). Transfected fibroblasts were plated at a density 
of 35 × 103 cells/well in a six well plate pre-coated with Matrigel hESC qualified, LDEV free (Corning) and cul-
tured in medium without antibiotics for the first two days, and then in TeSR-E7 one (StemCell Technologies) until 
the appearance of iPSCs colonies. iPSCs clones were isolated from distinct colonies by manual picking after 22–26 
days, and subsequently cultured using Matrigel coating and the mTESR1 medium (StemCell Technologies). 
The hiPSCs colonies were split using 0.5 mM EDTA in PBS. 1% RevitaCell Supplement 100 X (Thermo Fisher 
Scientific) was added after each passage to fresh mTESR1 medium overnight, to increase cell recovery. hiP-
SCs were cryopreserved in a solution containing 90% Knock Out Serum Replacement (KSR) (Thermo Fisher 
Scientific) and 10% DMSO (Sigma-Aldrich).
Nascent mRNA isolation, truseq RNA Access library preparation, sequencing and bioinformat-
ics analysis. Total RNA was purified from biological triplicates of treated and untreated neurons as described 
in the previous section and subjected to two rounds of oligo(dT) affinity capture using the Dynabeads mRNA 
purification Kit (Thermo Fisher Scientific) to recover the unbound poly(A)-minus fraction which is enriched 
for nascent RNA46. The poly(A)-minus fraction was then analysed by RT-PCR with RPPH1 and GAPDH probes 
to make sure that the depletion had been effective. For each samples, 10 ng of the poly(A)-minus RNA was used 
for library preparation using the TruSeq RNA Access library preparation kit (Illumina), which enriches for reads 
mapping to exons and allows a comprehensive coverage of coding RNA. Then, libraries were sequenced through 
a NextSeq 500 platform (Illumina) employing the 2 × 75 base pair (bp), paired end, HIGH flow cell sequencing 
(60 million reads/sample). Each experimental condition was tested as biological triplicate.
The bioinformatic analysis of the RNA-Seq raw dataset was carried our as follows. Briefly, counts genera-
tion was performed at both transcript-level and exon-level. Transcript-level reads were mapped to the reference 
human genome (hg19) with STAR v2.5.0, in stranded and pair-ends mode. Transcripts quantification was done 
with RSEM v 1.3.0 using GRCh37.75 ENSEMBL annotation. Exon-level reads mapping to the human genome 
(hg19) was done with bowtie v1.0.0, in stranded and pair-ends mode. Exons quantification was done using HTseq. 
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0.6.0 using GRCh37.75 ENSEMBL annotation after reorganizing exons features as requested by DEXSeq v1.12.2 
(R 3.3.0). For differential expression analysis of transcripts we used DESeq2 1.14.1 (|log2FC| ≥1 and adjusted 
p-value ≤ 0.1) while for exons we used DEXSeq v 1.20.2 (|log2FC| ≥1 and adjusted p-value ≤ 0.1). Hierarchical 
clustering analysis was done with TMEV v4.8.1 using as clustering parameters Euclidean distance and average 
linkage. Oligonucleotide primers for PCR assay were for RPPH1 (forward: 5′GTCTGAGACTAGGGCCAGAG; 
reverse: 5′CATCTCCTGCCCAGTCTGAC) and for GAPDH (forward 5′TCACCAGGGCTGCTTTTAAC; 
reverse 5′TGGAAGATGGTGATGGGATT).
RNA sequencing of KCl-depolarized neurons. Total RNA was purified from biological triplicates of 
treated and untreated neurons as described in the Real-Time quantitative PCR (qRT-PCR) section. Next gener-
ation sequencing experiments, comprising samples quality control and bioinformatics analysis, were performed 
by Genomix4life (Salerno, Italy). From each sample, indexed libraries were prepared from 50 ng of purified RNA 
with TruSeq RNA Access Sample Prep Kit (Illumina) according to the manufacturer’s instructions. Libraries 
were quantified using the TapeStation 4200 (Agilent Technologies) and Invitrogen Qubit fluorometer (Thermo 
Fisher Scientific), then pooled such that each index-tagged sample was present in equimolar amounts, with final 
concentration of the pooled samples of 2 nM. The pooled samples were subject to cluster generation and sequenc-
ing using an Illumina NextSeq 500 System (Illumina) in a 2 × 100 paired-end format at a final concentration of 
1.8 pmol. Fastq underwent to Quality Control using FastQC tool (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). To remove the adapter sequences, cutadapt47 was used. The mapping of paired-end reads was 
performed using STAR (version 2.5.1a)48 on reference genome assembly HG38 obtained from Gencode v2449. 
The quantification of expressed transcripts for each of the sequenced biological replicates was performed using 
Cuffnorm (http://cole-trapnell-lab.github.io/cufflinks/cuffnorm/) algorithm of the Cufflinks program50. Cuffdiff 
(http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/index.html) was used to perform the differential expression 
analysis. Differentially expressed genes were considered with cut-off of FDR ≤ 0.05 and Fold Change ≤ −1.5 for 
down genes and Fold Change ≥ 1.5 fo Up Genes. Gene Ontology Analysis (Biological Process; GO Ontology 
database Released 2017-10-24) was carried out using PANTHER (Protein ANalysis THrough Evolutionary 
Relationships) Classification System Version 12.0 (released 2017-07-10)51.
Use of human samples. For iPSC reprogramming, human dermal fibroblasts from normal donors (WT1 
and WT2) and from an A-T patient (A-T2) were obtained from the Coriell Institute Biobank (Camden, New 
Jersey, USA). Dermal fibroblasts for the sample labelled A-T1 were obtained from an A-T case for which an 
informed consent and Ethics committee approval was obtained at the The Children’s Memorial Health Institute 
(IPCZD), Warsaw.
Data Availability
The Exon Microarray data reported in this paper have been deposited in the Gene Expression Omnibus under 
GEO: GSE108605. Additional data generated during the current study are available from the corresponding au-
thor on request.
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